Patents by Inventor Kamalakar Talasila

Kamalakar Talasila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anthistamine-decongestant pharmaceutical compositions
    Patent number: 8263124
    Abstract: The present invention relates to pharmaceutical compositions of antihistamine-decongestant combination. Specifically the invention relates to bilayered tablet formulation comprising antihistaminic decongestant combination. More specifically present invention relates to the novel polymorph of fexofenadine or pharmaceutically accepted salts thereof, with at least one decongestant in the form of bilayered tablet. The preferred polymorphs are polymorph A and polymorph X of fexofenadine hydrochloride.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: September 11, 2012
    Assignees: Dr. Reddy's Laboratories Limited, Dr. Reddy's Laboratories, Inc.
    Inventors: Kamalakar Talasila, Debashis Dash, Srinivas Irukula, Dhanorkar Vipin Tatyasaheb, Mailatur Sivaraman Mohan
  • PHARMACEUTICAL COMPOSITION CONTAINING 1H-INDEN-1-AMINE, 2,3-DIHYDRO-N-2-PROPYNYL-(1R)-, METHANESULFONATE
    Publication number: 20120122993
    Abstract: A pharmaceutical composition comprising as an active ingredient a therapeutically effective amount of R(+)-N-propargyl-1-aminoindan mesylate thereof, and less than 50% by weight of hexahydric sugar alcohols.
    Type: Application
    Filed: March 4, 2010
    Publication date: May 17, 2012
    Applicant: SANDOZ AG
    Inventors: Kamalakar Talasila, Hemant Narkhede, Atul Daroi
  • STABLE AND BIOAVAILABLE FORMULATIONS AND A NOVEL FORM OF DESLORATADINE
    Publication number: 20100022576
    Abstract: An active pharmaceutical ingredient comprising 95% of form I of desloratadine and 5% of form II of desloratadine is disclosed. Also disclosed are a process for its preparation as well as a bioavailable and stable formulation containing this active pharmaceutical ingredient for the treatment of allergic diseases like allergic rhinitis, chronic idiopathic urticaria, asthma and other similar diseases. The compositions are formulated such as to provide protection to the drug from acidic excipients. The compositions of the present invention comprise desloratadine intimately mixed with hydrogenated vegetable oil and certain other excipients including acidic excipients.
    Type: Application
    Filed: June 5, 2007
    Publication date: January 28, 2010
    Inventors: Ramaswami Bharatrajan, Kamalakar Talasila
  • Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions
    Publication number: 20060182800
    Abstract: The present invention relates to pharmaceutical compositions of antihistamine-decongestant combination. Specifically the invention relates to bilayered tablet formulation comprising antihistaminic decongestant combination. More specifically present invention relates to the novel polymorph of fexofenadine or pharmaceutically accepted salts thereof, with at least one decongestant in the form of bilayered tablet. The preferred polymorphs are polymorph A and polymorph X of fexofenadine hydrochloride.
    Type: Application
    Filed: April 4, 2002
    Publication date: August 17, 2006
    Inventors: Kamalakar Talasila, Debashi Dash, Srinivas Irukula, Dhanorkar Tatyasaheb, Mailatur Mohan